9139

antibody from Cell Signaling Technology, Inc

Targeting: STAT3 APRF

Western blot (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Chromatin Immunoprecipitation (Data presented on provider website)

Antibody Data

Product number

9139

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#9139, RRID:AB_331757

Product name

Stat3 (124H6) Mouse mAb

Antibody type

Monoclonal

Reactivity

Human, Mouse, Rat, Simian

Host

Mouse

Storage

-20°C

References

Submitted references

miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma.

Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N, Mano H, Sugimoto K, Miyazono K
Blood 2011 Dec 22;118(26):6881-92

---

TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer.

Yao Z, Fenoglio S, Gao DC, Camiolo M, Stiles B, Lindsted T, Schlederer M, Johns C, Altorki N, Mittal V, Kenner L, Sordella R
Proceedings of the National Academy of Sciences of the United States of America 2010 Aug 31;107(35):15535-40

---

Modulation of PKCdelta signaling alters the shear stress-mediated increases in endothelial nitric oxide synthase transcription: role of STAT3.

Sud N, Kumar S, Wedgwood S, Black SM
American journal of physiology. Lung cellular and molecular physiology 2009 Mar;296(3):L519-26